• Citer

Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide.

par Praga, Claudio;Bergh, Jonas;Bliss, Judith M;Bonneterre, J;Cesana, Bruno;Coombes, Raoul Charles;Fargeot, Pierre;Folin, Annika;Fumoleau, Pierre;Giuliani, Rosa;Kerbrat, Pierre;Hery, Michel;Nilsson, Jonas;Onida, Francesco;Piccart-Gebhart, Martine ;Shepherd, L;Therasse, P.;Wils, J;Rogers, David
Référence Journal of clinical oncology, 23, 18, page (4179-4191)
Publication Publié, 2005-06

Article révisé par les pairs

• Détails
• Contenu

Titre:	Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide.
Auteur:	Praga, Claudio; Bergh, Jonas; Bliss, Judith M; Bonneterre, J; Cesana, Bruno; Coombes, Raoul Charles; Fargeot, Pierre; Folin, Annika; Fumoleau, Pierre; Giuliani, Rosa; Kerbrat, Pierre; Hery, Michel; Nilsson, Jonas; Onida, Francesco; Piccart-Gebhart, Martine; Shepherd, L; Therasse, P.; Wils, J; Rogers, David
Informations sur la publication:	Journal of clinical oncology, 23, 18, page (4179-4191)
Statut de publication:	Publié, 2005-06
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adult
	Antineoplastic Combined Chemotherapy Protocols -- adverse effects
	Breast Neoplasms -- drug therapy
	Chemotherapy, Adjuvant -- adverse effects
	Cyclophosphamide -- adverse effects
	Cyclophosphamide -- therapeutic use
	Data Interpretation, Statistical
	Epirubicin -- adverse effects
	Epirubicin -- therapeutic use
	Female
	Follow-Up Studies
	Humans
	Leukemia, Myeloid, Acute -- chemically induced
	Middle Aged
	Myelodysplastic Syndromes -- chemically induced
	Randomized Controlled Trials as Topic
	Risk Factors
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:0732-183X
	info:doi/10.1200/JCO.2005.05.029
	info:pii/23/18/4179
	info:pmid/15961765